Ximei Wang
This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Ximei Wang (王喜梅), a licensed Representative with CE reference BPX026. Currently licensed at 1 firm(s): Going Securities Limited. Active regulated activities: Type 1 - Dealing in securities; Type 2 - Dealing in futures contracts; Type 4 - Advising on securities; Type 5 - Advising on futures contracts; Type 9 - Asset management. This person has 2.9 years of SFC licence history. Total licence records on file: 10.
Information
- LinkedIn:
- Email:
Licence history
| Firm | Role | Regulated activity | From | To |
|---|---|---|---|---|
| Going Securities Limited 高盈證券有限公司 |
Rep | Type 2 - Dealing in futures contracts | 2025-08-01 | present |
| Going Securities Limited 高盈證券有限公司 |
Rep | Type 5 - Advising on futures contracts | 2025-08-01 | present |
| Going Securities Limited 高盈證券有限公司 |
Rep | Type 1 - Dealing in securities | 2025-02-27 | present |
| Going Securities Limited 高盈證券有限公司 |
Rep | Type 4 - Advising on securities | 2025-02-27 | present |
| Going Securities Limited 高盈證券有限公司 |
Rep | Type 9 - Asset management | 2025-02-27 | present |
| First Quarter Moon Asset Management Limited 上弦月資產管理有限公司 |
Rep | Type 4 - Advising on securities | 2024-11-11 | 2024-12-11 |
| First Quarter Moon Asset Management Limited 上弦月資產管理有限公司 |
Rep | Type 9 - Asset management | 2024-11-11 | 2024-12-11 |
| Ark Securities (Hong Kong) Limited 同舟證券(香港)有限公司 |
Rep | Type 1 - Dealing in securities | 2020-09-24 | 2022-03-08 |
| Ark Securities (Hong Kong) Limited 同舟證券(香港)有限公司 |
Rep | Type 4 - Advising on securities | 2020-09-24 | 2022-03-08 |
| Ark Securities (Hong Kong) Limited 同舟證券(香港)有限公司 |
Rep | Type 9 - Asset management | 2020-09-24 | 2022-03-08 |
Worked alongside
The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Ximei Wang during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.